BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3480633)

  • 21. [Drug stimulation of the healing of suppurative wounds of the maxillofacial area].
    Agapov VS; Liapunov NA; Trukhina GM; Tarasenko SV
    Stomatologiia (Mosk); 1996; Spec No():41-2. PubMed ID: 9281127
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of quercetin granules for treating suppurative soft-tissue wounds of the maxillofacial area and neck].
    Timofeev AA; Maksiutina NP; Voĭtenko GN; Dobrovol'skiĭ IuN
    Stomatologiia (Mosk); 1989; 68(6):11-3. PubMed ID: 2623676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The intestinal microflora of patients with inflammatory diseases of the maxillofacial area].
    Bevz NI; Budanova EV; Pashkov EP; Ter-Asaturov GP; Goncharova GI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):22-4. PubMed ID: 7992527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Supersorbicid in comprehensive treatment of acute pyoinflammatory processes in maxillofacial region].
    Eshbadalov KhIu
    Stomatologiia (Mosk); 2005; 84(2):36-7. PubMed ID: 15798751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of chlorhexidine effectiveness in treating acute inflammatory processes of the maxillofacial region].
    Gapanenko TG; Pecherkina SA; Kislykh FI; Dudin AB
    Stomatologiia (Mosk); 1983; 62(1):41-3. PubMed ID: 6572436
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons].
    Durnovo EA; Furman IV
    Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The evaluation of the body hormonal status of patients with phlegmons of the maxillofacial area].
    Seidbekov OS
    Stomatologiia (Mosk); 1991; 70(3):32-4. PubMed ID: 1926202
    [No Abstract]   [Full Text] [Related]  

  • 28. [The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus].
    Babenkov HD; Dolhopolov VV; Potiĭ VV; Shypilov KV; Peleshenko OS
    Klin Khir; 2006 Jul; (7):58-60. PubMed ID: 17115602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood amino acid composition in inflammatory diseases of the maxillofacial area].
    Shcherbatiuk DI; Anestiiadi MIa
    Stomatologiia (Mosk); 1980; 59(5):29-31. PubMed ID: 6932749
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relationship of the indices of the T-, B- and A-immune systems of patients with phlegmons of the maxillofacial area].
    Robustova TG; Lebedev KA; Ushakov RV; Poniakina ID
    Stomatologiia (Mosk); 1985; 64(4):35-7. PubMed ID: 3876620
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of a spiramycin-metronidazole combination in the treatment of acute, circumscribed perimaxillary cellulitis].
    Feki A
    Chir Dent Fr; 1981 Dec; 51(136):49-51. PubMed ID: 6948670
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in the blood osmotic state as affected by hyperbaric oxygenation in patients with acute inflammation of the maxillofacial area].
    Aleksandrov VN; Shpektor VA; Sredniakov VA; Maksimov BN; Markin SA
    Stomatologiia (Mosk); 1983; 62(4):43-5. PubMed ID: 6578619
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vacuum drainage and local oxygen therapy in treating patients with abscesses and phlegmons of the maxillofacial area].
    Ol'shevskiĭ VA
    Stomatologiia (Mosk); 1983; 62(2):43-5. PubMed ID: 6574633
    [No Abstract]   [Full Text] [Related]  

  • 34. [The antioxidant correction of lipid peroxidation in maxillofacial phlegmons].
    Gavriliuk LA; Lungu SE; Shcherbatiuk DI
    Stomatologiia (Mosk); 1994; 73(2):33-5. PubMed ID: 9612045
    [No Abstract]   [Full Text] [Related]  

  • 35. [Differentiated premedication in the treatment of odontogenic phlegmons of the maxillofacial area].
    Vovk IuV; Gotsko EV; Kaminskiĭ VI
    Stomatologiia (Mosk); 1988; 67(5):40-2. PubMed ID: 3212805
    [No Abstract]   [Full Text] [Related]  

  • 36. [Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
    Shimchenko PIa; Morozov VG; Khavinson VKh; Orlov VS
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):94-7. PubMed ID: 6895567
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intercellular relationships in the dynamic development and maturation of granular tissue in suppurative wounds of the maxillofacial area studied by correlation analysis].
    Bazhanov NN; Mukhsinov ME; Pol'skiĭ VI; Aleksandrov MT
    Stomatologiia (Mosk); 1988; 67(6):4-6. PubMed ID: 3238715
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of clamoxyl (amoxicillin) in odontostomatologic infections].
    Commissionat Y
    Rev Odontostomatol (Paris); 1977; 6(3):227-9. PubMed ID: 269472
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled clinical trial of Tetranase in dental practice].
    Vespa N
    Minerva Med; 1972 Aug; 63(59 Suppl):3219-225. PubMed ID: 4559750
    [No Abstract]   [Full Text] [Related]  

  • 40. [The possibilities of using clinical blood analysis for the prognosis of the course of acute suppurative inflammatory processes in the soft tissues of the maxillofacial area].
    Kurakin AV; Kuznetsova OI; Meshcheriakov DG
    Stomatologiia (Mosk); 1991; 70(1):35-7. PubMed ID: 2057948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.